YVETTE JOHNSON: Open Payments
NPI 1043608631 · HARVEY, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 29 payments from 9 companies in 2025. Trend: 2023 $1,527 · 2024 $683 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $161 |
| E.R. Squibb & Sons, L.L.C. | 8 | $135 |
| ABBVIE INC. | 3 | $76 |
| Alkermes, Inc. | 3 | $50 |
| Neurocrine BioSciences, Inc. | 3 | $49 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Luye Pharma (USA) Ltd. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: REXULTI, COBENFY, VRAYLAR, ARISTADA, INGREZZA, SPRAVATO, CAPLYTA, ERZOFRI EXTENDED-RELEASE.
Industry payments across IL — which companies pay providers there.
